Cocrystal Pharma (COCP) Long-Term Investments (2010 - 2020)

Cocrystal Pharma has reported Long-Term Investments for 8 years, with the latest figure at $837000.0 in Q4 2020.

• Quarterly Long-Term Investments rose 9.84% year-over-year to $837000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $837000.0 (up 9.84% YoY) and the FY2020 annual result came in at $837000.0, up 9.84% from the prior year.
• Long-Term Investments advanced to $837000.0 in Q4 2020 per COCP's latest filing, from $762000.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $1.3 million in Q4 2016 and troughed at $762000.0 in Q4 2019.
• A 5-year average of $940400.0 and a median of $837000.0 in 2020 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2016 and 2017: Long-Term Investments rose 20.49% in 2016, then dropped 27.36% in 2017.
• Over 5 years, Long-Term Investments stood at $1.3 million in 2016, then decreased by 27.36% to $961000.0 in 2017, then retreated by 14.78% to $819000.0 in 2018, then dropped by 6.96% to $762000.0 in 2019, then gained by 9.84% to $837000.0 in 2020.
• According to Business Quant data, Long-Term Investments over the past three periods registered $837000.0, $762000.0, and $819000.0 for Q4 2020, Q4 2019, and Q4 2018 respectively.